Torray Investment Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8M | Sell |
688,776
-173,242
| -20% | -$6.24M | 3.6% | 3 |
|
|
2025
Q1 | $26.8M | Buy |
862,018
+178,011
| +26% | +$5.54M | 4% | 1 |
|
|
2024
Q4 | $17.4M | Sell |
684,007
-173,912
| -20% | -$4.44M | 2.5% | 9 |
|
|
2024
Q3 | $24.3M | Buy |
857,919
+164,361
| +24% | +$4.65M | 3.4% | 4 |
|
|
2024
Q2 | $18.3M | Buy |
693,558
+23,498
| +4% | +$620K | 2.73% | 5 |
|
|
2024
Q1 | $20.3M | Buy |
670,060
+164,320
| +32% | +$4.99M | 3.05% | 4 |
|
|
2023
Q4 | $14.2M | Buy |
505,740
+93,107
| +23% | +$2.62M | 2.3% | 13 |
|
|
2023
Q3 | $11.2M | Sell |
412,633
-1,182
| -0.3% | -$32.1K | 1.98% | 20 |
|
|
2023
Q2 | $12.7M | Buy |
413,815
+276,643
| +202% | +$8.5M | 2.2% | 16 |
|
|
2023
Q1 | $4.94M | Sell |
137,172
-199
| -0.1% | -$7.17K | 0.89% | 44 |
|
|
2022
Q4 | $5.43M | Sell |
137,371
-1,653
| -1% | -$65.3K | 0.98% | 37 |
|
|
2022
Q3 | $5.59M | Buy |
139,024
+12
| +0% | +$482 | 1.11% | 33 |
|
|
2022
Q2 | $5.84M | Buy |
139,012
+6,942
| +5% | +$292K | 1.11% | 34 |
|
|
2022
Q1 | $5.15M | Sell |
132,070
-5,871
| -4% | -$229K | 0.83% | 45 |
|
|
2021
Q4 | $5.5M | Buy |
+137,941
| New | +$5.5M | 0.81% | 51 |
|